SEC Filing Summary: ChromaDex Corporation (8-K)
Business Context and Reporting Period
Company: ChromaDex Corporation (Note: The request metadata listed "Niagen Bioscience, Inc.", but the filing text identifies the registrant as ChromaDex Corporation).
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2018
Event: Regulation FD Disclosure regarding a corporate presentation released for the 30th Annual ROTH Capital Partners Conference.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the release of an investor presentation (Exhibit 99.1) and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document references a presentation but does not summarize its contents or compare periods.
Guidance, Outlook, and Risks
Management Commentary: The company released a corporate presentation on March 12, 2018, intended for use at the ROTH Capital Partners Conference.
Legal Status of Information: The information furnished in this report and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and is not incorporated by reference into other filings unless expressly stated.
Risks/Contingencies: No specific risks or contingencies are listed in the text of this filing.
Investor Verification Checklist
- Verify the contents of the attached Exhibit 99.1 (Investor Presentation) for specific financial data and guidance, as the 8-K text itself contains no numbers.
- Confirm the company name is ChromaDex Corporation, not Niagen Bioscience, Inc.
- Note that the presentation materials are "furnished" and not "filed," meaning they carry different legal liability standards than standard financial reports.
- Check the company's website for the full text of the March 12, 2018, presentation referenced in Item 7.01.